Back
iRhythm Technologies Vs. Oramed Pharmaceuticals Industry Stock Comparison
Buy
56
IRTC
iRhythm Technologies
Last Price:
112.60
Seasonality Move:
6.75%
Sell
30
ORMP
Oramed Pharmaceuticals
Last Price:
2.26
Seasonality Move:
7.52%
Buy
56
iRhythm Technologies (IRTC)
is a Buy
Is iRhythm Technologies a Buy, Sell or Hold?
- The current iRhythm Technologies [IRTC] share price is $116.43. The Score for IRTC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- IRTC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
- The current Oramed Pharmaceuticals [ORMP] share price is $2.37. The Score for ORMP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ORMP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRTC Stock Price Chart
What is iRhythm Technologies's stock price today?
-
The iRhythm Technologies share price today is $116.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IRTC is experiencing slight selling pressure.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.
IRTC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 59.83 | Buy |
| Chaikin Money Flow: | -82035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (109.16 - 115.22) | Buy |
| Bollinger Bands (100): | (100.62 - 118.02) | Buy |
ORMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 39.24 | Sell |
| Chaikin Money Flow: | 21618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.4 - 2.84) | Sell |
| Bollinger Bands (100): | (2.25 - 3.01) | Sell |
IRTC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.68 | Buy |
| 20-day SMA: | 112.68 | Buy |
| 50-day SMA: | 111.39 | Buy |
| 200-day SMA: | 101.33 | Buy |
| 8-day EMA: | 113.86 | Buy |
| 20-day EMA: | 112.58 | Buy |
| 50-day EMA: | 111.32 | Buy |
| 200-day EMA: | 106.51 | Buy |
ORMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Buy |
| 20-day SMA: | 2.56 | Sell |
| 50-day SMA: | 2.86 | Sell |
| 200-day SMA: | 2.66 | Sell |
| 8-day EMA: | 2.38 | Sell |
| 20-day EMA: | 2.52 | Sell |
| 50-day EMA: | 2.66 | Sell |
| 200-day EMA: | 2.91 | Sell |
iRhythm Technologies Earnings Growth & IRTC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.14 per share, and an increase next year of $1.11 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.00 per share.
iRhythm Technologies Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oramed Pharmaceuticals Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||